Get started
Author

Francesco Benito Malandrini

Observed names: F Malandrini, F.B. Malandrini, FB Malandrini, Francesco Malandrini, Malandrini, Francesco
ORCID: 0000-0002-0245-9849
Observed ORCID: 0000-0002-0245-9849
OpenAlex ID: A5083810753
EQ-5D-5L Population Norms for Italy
2022 · Michela Meregaglia, Francesco Malandrini, et al. · Applied Health Economics and Health Policy · 44
PDF
The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022
2023 · Michela Meregaglia, Francesco Malandrini, et al. · Applied Health Economics and Health Policy · 32
PDF
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
2023 · Alice Tarantola, Monica Hildegard Otto, et al. · Journal of Pharmaceutical Policy and Practice · 26
PDF
The development of an archive of patient-reported outcome measures (PROMs) in oncology: The Italian PRO4All project
2024 · Francesco Malandrini, Michela Meregaglia, et al. · European Journal of Cancer · 12
PDF
Regulatory readiness for innovation: a mixed-methods study of national competent authority professional and organizational capacities in the context of pre-market clinical investigations and early feasibility studies
2026 · Majella Geraghty, Francesco Malandrini, et al. · Expert Review of Medical Devices · 9
PDF
Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project
2024 · Anna Amela Valsecchi, Filippo Giovanardi, et al. · The Breast · 4
PDF
P58 EQ-5D-5L Population Norms for Italy
2022 · M Meregaglia, AP Finch, et al. · Value in Health · 2
The role of patient-reported outcomes in reimbursement decisions and drug innovation in Italy
2023 · Francesco Malandrini, Cesare Borroni, et al. · Global & Regional Health Technology Assessment · 1
PDF
Patient reported outcome measures in spinal muscular atrophy and duchenne muscular dystrophy: review of instruments and their inclusion in clinical and regulatory processes
2026 · Francesco Malandrini, Clarissa Spataro, et al. · Neurological Sciences
PDF
Regulatory readiness for innovation: a mixed-methods study of national competent authority professional and organizational capacities in the context of pre-market clinical investigations and early feasibility studies
2026 · Geraghty, Majella, Malandrini, Francesco, et al. · Figshare
MT31 National Competent Authorities’ Experiences With Early Feasibility Study Assessment: Promoting Dialogue, Supporting Sponsors, and Fostering Shared Learning to Harmonize the EU Framework
2025 · Federico Facciolo, Franco Luigi Zurlo, et al. · Value in Health
HPR62 Do Patient-Reported Outcomes Influence Drug Prices? Evidence From the Italian Pricing and Reimbursement System
2025 · Vittoria Ardito, Francesco Benito Malandrini, et al. · Value in Health
MT13 Challenges of Pre-Market Clinical Investigations of Medical Devices: A Multi-Stakeholder Perspective
2025 · Giuditta Callea, Rosanna Tarricone, et al. · Value in Health
HPR67 Global Assessment of Pre-Market Approval Pathways for Medical Devices: Highlighting the Need for Harmonization Across 55 Jurisdictions
2024 · FB Malandrini, G Callea, et al. · Value in Health
PCR1 The Development of a Comprehensive Repository of Patient-Reported Outcome Measures (PROMs) for Spinal Muscular Atrophy and Duchenne Muscular Dystrophy
2024 · F.B. Malandrini, M. Meregaglia, et al. · Value in Health
PDF
PCR17 The Development of a Comprehensive Archive of Patient-Reported Outcome Measures (PROMS) for Clinical Research and Clinical Practice in Oncology
2023 · F.B. Malandrini, M. Meregaglia, et al. · Value in Health
PDF
HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021
2022 · M Meregaglia, F Malandrini, et al. · Value in Health
Works count: 17
Citation count: 130
H-index: 5
I10-index: 4
Year
Topic
Type